Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Mahjoubi · SciRah

Researcher profile · Semantic Scholar

L. Mahjoubi

Share profile

L. Mahjoubi — researcher profile on SciRah

h-index: 12
Works: 43
Citations: 940

Most-cited papers

New insights into the role of EMT in tumor immune escape
S. Terry, P. Savagner, S. Ortiz-Cuàran, L. Mahjoubi +3 more
2017Molecular Oncology401 citations Open access
Semantic Scholar
Diverse resistance mechanisms to the third-generation ALK inhibitor lorlatinib in ALK-rearranged lung cancer
G. Recondo, L. Mezquita, F. Facchinetti, D. Planchard +37 more
2019Clinical Cancer Research156 citations Open access
Semantic Scholar
Crizotinib-Resistant ROS1 Mutations Reveal a Predictive Kinase Inhibitor Sensitivity Model for ROS1- and ALK-Rearranged Lung Cancers
F. Facchinetti, Y. Loriot, Mei-Shiue Kuo, L. Mahjoubi +10 more
2016Clinical Cancer Research141 citations
Semantic Scholar
Rapid and objective CT scan prognostic scoring identifies metastatic patients with long-term clinical benefit on anti-PD-1/-L1 therapy.
L. Dercle, S. Ammari, S. Champiat, C. Massard +11 more
2016European Journal of Cancer66 citations
Semantic Scholar
TROP-2 directed antibody-drug conjugates (ADCs): The revolution of smart drug delivery in advanced non-small cell lung cancer (NSCLC).
C. Parisi, L. Mahjoubi, A. Gazzah, F. Barlesi
2023Cancer Treatment Reviews43 citations
Semantic Scholar
Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy
G. Recondo, L. Mahjoubi, A. Maillard, Y. Loriot +30 more
2020npj Precision Oncology27 citations Open access
Semantic Scholar
Hepatic arterial infusion of oxaliplatin plus systemic chemotherapy and targeted therapy for unresectable colorectal liver metastases.
A. Boilève, A. De Cuyper, A. Larive, L. Mahjoubi +9 more
2020European Journal of Cancer22 citations Open access
Semantic Scholar
A never-smoker lung adenocarcinoma patient with a MET exon 14 mutation (D1028N) and a rapid partial response after crizotinib
L. Mahjoubi, A. Gazzah, B. Besse, L. Lacroix +1 more
2016Investigational new drugs22 citations
Semantic Scholar
A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours.
A. Gazzah, V. Boni, J. Soria, A. Calles +8 more
2018European Journal of Cancer14 citations
Semantic Scholar
Invasive cutaneous infection due to Scopulariopsis brevicaulis unsuccessfully treated with high-dose micafungin in a neutropenic patient
Daniel Gavril, P. Woerther, A. Ben Lakhdar, L. Mahjoubi +6 more
2017Infection14 citations
Semantic Scholar
Incidence of Lung Adenocarcinoma Biomarker in a Caribbean and African Caribbean Population
N. Leduc, C. Ahomadégbé, M. Agossou, A. Aline-Fardin +7 more
2016Journal of Thoracic Oncology14 citations Open access
Semantic Scholar
Profile and outcome of cancer patients enrolled in contemporary phase I trials.
E. Alouani, A. Gazzah, S. Mercier, R. Bahleda +11 more
2023European Journal of Cancer12 citations Open access
Semantic Scholar
Late-occurring nivolumab-induced cryptogenic organising pneumonia mimicking lung progression in a patient with metastatic non-small cell lung cancer.
L. Mahjoubi, A. Gazzah, A. Marabelle, F. Le Roy Ladurie +5 more
2017European Journal of Cancer5 citations
Semantic Scholar
1659P The use of liquid biopsy in patients with advanced pancreatic cancer (PDAC) to guide enrollment in phase I clinical trials
O. Letissier, C. Smolenschi, A. Hollebecque, D. Vasseur +15 more
2023Annals of Oncology1 citations Open access
Semantic Scholar
Abstract 318: Mechanisms of acquired resistance to FGFR inhibitors in molecularly-selected solid tumors: A prospective cohort from the MATCH-R study
F. Facchinetti, R. Bahleda, A. Hollebecque, Y. Loriot +29 more
2019Experimental and Molecular Therapeutics1 citations
Semantic Scholar
Personalized therapy based on sequential molecular analysis leads to 30 months of survival in a patient with diffuse unresectable gastric linitis plastica
L. Mahjoubi, F. Cecchi, C. Massard, F. Calabrò +13 more
2018Tumori1 citations
Semantic Scholar
1168PEstimation of benefice to anti-PD-(L)1 for metastatic patients by real-time quantitative and functional estimation of immune infiltrate with RNAseq
L. Verlingue, L. Mahjoubi, D. Brandao, S. Michiels +16 more
20171 citations Open access
Semantic Scholar
Phase Ib study of afatinib plus standard-dose cetuximab in patients with advanced solid tumours
A. Gazzah, V. Boni, J. Soria, A. Calles +8 more
20161 citations
Semantic Scholar
Gustave Roussy Immune Score Validation in Patients Treated with Bispecific CD3 T-cell Engagers in Phase I Clinical Trials
Noé Herbel, Clara Helal, K. Ouali, F. Danlos +21 more
2026Cancer Research Communications0 citations Open access
Semantic Scholar
Abstract B083: The use of liquid biopsy in patients with advanced pancreatic cancer (PDAC) to guide enrollment in phase I clinical trials
O. Letissier, C. Smolenschi, A. Hollebecque, D. Vasseur +16 more
2024Cancer Research0 citations
Semantic Scholar
Dedicated overseas consultation for patients evacuated from the south Pacific: Report of experience after six months of existence.
N. Epaillard, A. Géraud, G. Garcia, R. Flippot +16 more
2023Journal of Clinical Oncology0 citations Open access
Semantic Scholar
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.
J. Michot, M. Guerra, C. Quivoron, L. Mahjoubi +9 more
2023Hematological Oncology0 citations Open access
Semantic Scholar
CAROLINE study: Incidence and characterization of melanoma in French Polynesia.
N. Epaillard, É. Auclin, E. Hirigoyen, Luc Bermond +9 more
2023Journal of Clinical Oncology0 citations
Semantic Scholar
Abstract P2-13-02: COBRA: Characteristics and Outcomes of patients with BReast cancer in phAse I trials at Gustave Roussy Cancer center
L. Seknazi, A. Géraud, V. Goldschmidt, C. Baldini +19 more
2023Cancer Research0 citations
Semantic Scholar
1845P Exclusion of patients with psychiatric disorders from early phase oncology trials: A limited access to innovation?
P. Matte, M. Delaye, A. Mc Govern, K. Ouali +16 more
2023Annals of Oncology0 citations Open access
Semantic Scholar
461P Overview of patients inclusions and outcomes into modern phase I trials at Gustave Roussy over the last 5 years, OVATION study
E. Alouani, A. Gazzah, S. Mercier, R. Bahleda +10 more
2022Annals of Oncology0 citations Open access
Semantic Scholar
Use of the Geriatric Core Dataset for older patients included in early phase trials
L. Seknazi, V. Goldschmidt, S. Champiat, A. Hollebecque +14 more
2022Journal of Geriatric Oncology0 citations
Semantic Scholar
High prevalence of Clonal Hematopoiesis of indeterminate potential (CHIP) associated mutations in elderly patients with solid tumors
J. E. Rodríguez, A. Bayle, A. Pagès, F. Danlos +17 more
2022Journal of Geriatric Oncology0 citations
Semantic Scholar
444P Incidence of cancer diagnosis and cancer care before and after the COVID-19 pandemic in French Polynesia TEAHUPOO study
E. Hirigoyen, N. Epaillard, M. Chastenet, R. Hervé +3 more
2022Annals of Oncology0 citations Open access
Semantic Scholar
Corrigendum to 'A phase 1b study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours' [Eur J Cancer 104 (November 2018) 1-8].
A. Gazzah, V. Boni, J. Soria, A. Calles +8 more
2019European Journal of Cancer0 citations
Semantic Scholar
Abstract 311: Diverse biological mechanisms drive resistance to Lorlatinib in ALK-rearranged Lung Cancer
G. Recondo, L. Mezquita, D. Planchard, A. Gazzah +30 more
2019Experimental and Molecular Therapeutics0 citations
Semantic Scholar
Medical image computing to assess tumor infiltrating CD8 T cells, tumor immune phenotype and response to anti-PD-1/PD-L1 immunotherapy in prospective phase 1 trials.
R. Sun, E. Limkin, M. Vakalopoulou, L. Dercle +15 more
20180 citations
Semantic Scholar
3 1 . 1 Immune Checkpoints
L. Mahjoubi, N. Rizvi, A. Marabelle
20180 citations
Semantic Scholar
1703PDLandscape of DNA damage response (DDR) genes alterations in the prospective MOSCATO and MATCH R trials
Y. El-Dakdouki, L. Verlingue, C. Massard, R. Bahleda +11 more
20170 citations Open access
Semantic Scholar
1165P Immune checkpoint inhibitors following targeted therapies in MITF family translocation renal cell carcinomas
A. Boilève, M. Carlo, P. Barthélémy, S. Oudard +35 more
20170 citations
Semantic Scholar
Abstract 1011: RNAseq analysis obtained from on-purpose tumor biopsies of patients in the MATCH-R trial allows the identification of potential mechanisms of acquired resistance to PD(L)1 therapies
L. Verlingue, L. Mahjoubi, S. Aspeslagh, Marion Pedrero +16 more
20170 citations
Semantic Scholar
Données préliminaires de l’étude MATCH R
L. Mahjoubi
20170 citations
Semantic Scholar
Description and prognostic value of the mutational load across various metastatic solid tumors in the prospective MOSCATO-01 and MATCH-R trials
L. Mahjoubi, M. Pedredo, C. Massard, E. Álvarez +5 more
20160 citations Open access
Semantic Scholar
Rapid and objective CT-scan prognostic scoring identifies patients with long-term clinical benefit on phase I trials
L. Dercle, S. Ammari, S. Champiat, C. Massard +14 more
20160 citations Open access
Semantic Scholar
Lung Adenocarcinoma Biomarker Incidence in a Caribbean and African-Caribbean Population
N. Leduc, C. Ahomadégbé, M. Agossou, A. Aline-Fardin +7 more
20160 citations
Semantic Scholar
Congrès Targeted Anticancer Therapies — TAT 2015
Z. Ajgal, A. Bellesoeur, C. Baylot, C. Bigenwald +18 more
2015ONCOLOGIE0 citations
Semantic Scholar
Rare metastasis to the iris from renal cell carcinoma responds to an anti-angiogenic therapy – a case report
L. Mahjoubi, J. Marie-Louise, H. Merle, V. Molinie
20140 citations Open access
Semantic Scholar
Characterization of DLC films deposited on silicon by the MW ECR-pacvd method
A. Khettache, L. Mahjoubi, M. Z. Touhami, B. Bouzabata +2 more
20050 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Gazzah×20
Invite
A. Gazzah — researcher profile on SciRah
A. Hollebecque×18
Invite
A. Hollebecque — researcher profile on SciRah
J. Soria×16
Invite
J. Soria — researcher profile on SciRah
Y. Loriot×13
Invite
Y. Loriot — researcher profile on SciRah

×11

Invite

A. Marabelle — researcher profile on SciRah

Invite

L. Lacroix — researcher profile on SciRah

Invite

C. Massard — researcher profile on SciRah

Invite

R. Bahleda — researcher profile on SciRah

Invite

J. Scoazec — researcher profile on SciRah

Invite

F. André — researcher profile on SciRah

Invite

B. Besse — researcher profile on SciRah

Invite

É. Solary — researcher profile on SciRah